应激激酶 p38α 作为癌症治疗的靶点。
The Stress Kinase p38α as a Target for Cancer Therapy.
机构信息
Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain.
Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
出版信息
Cancer Res. 2015 Oct 1;75(19):3997-4002. doi: 10.1158/0008-5472.CAN-15-0173. Epub 2015 Sep 16.
p38α is a ubiquitous protein kinase strongly activated by stress signals, inflammatory cytokines, and many other stimuli, which has been implicated in the modulation of multiple cellular processes. There is good evidence in the literature that p38α plays an important tumor-suppressor role by interfering with malignant cell transformation. This is mainly based on the ability of the p38α pathway to regulate tissue homeostasis by integrating signals that balance cell proliferation and differentiation or induce apoptosis. However, recent reports have also illustrated protumorigenic functions for p38α. Thus, p38α signaling may facilitate the survival and proliferation of tumor cells contributing to the progression of some tumor types. In addition, p38α activation helps tumor cells to survive chemotherapeutic treatments. In all these cases, the inhibition of p38α has a potential therapeutic interest. Further elucidation of the context-dependent functions of p38α signaling in tumoral processes is of obvious importance for the use of inhibitors of this pathway in cancer therapy.
p38α 是一种普遍存在的蛋白激酶,强烈地被应激信号、炎性细胞因子和许多其他刺激激活,其与多种细胞过程的调节有关。文献中有充分的证据表明,p38α 通过干扰恶性细胞转化,发挥重要的肿瘤抑制作用。这主要是基于 p38α 途径通过整合平衡细胞增殖和分化或诱导细胞凋亡的信号来调节组织平衡的能力。然而,最近的报道也说明了 p38α 的促肿瘤形成功能。因此,p38α 信号可能有助于肿瘤细胞的存活和增殖,促进某些肿瘤类型的进展。此外,p38α 的激活有助于肿瘤细胞耐受化疗药物治疗。在所有这些情况下,抑制 p38α 具有潜在的治疗意义。进一步阐明 p38α 信号在肿瘤发生过程中的上下文相关功能,对于在癌症治疗中使用该途径的抑制剂具有重要意义。